Frederick W. Driscoll

Filings by Frederick W. Driscoll span 6 companies, the busiest being Flexion Therapeutics Inc, ImmunityBio, Inc. and Genelabs Technologies Inc /CA. In total, 29 filings cover trades dated from 28 November 2007 to 19 November 2021.

Market trades split into 6 purchases (€172k) and 7 sales (€1.3M). Netting one side against the other leaves €1.2M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants and 2 option exercises. In 2021 alone, the filings show 1 purchase and 1 sale.

In size, the median ticket on the buying side is €19k. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

Most recently, on 19 November 2021, the filings show a transaction worth €229k in Flexion Therapeutics Inc. The last insider purchase was made public on 7 September 2021, 1,873 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.